Jeffrey W. Greve
Directeur Financier/CFO chez SAGENT PHARMACEUTICALS INC
Profil
Jeffrey W.
Greve is currently the Executive Vice President-Global Finance at Sagent Pharmaceuticals, Inc. He started this position in 2017.
Prior to his current role, he has an undergraduate degree from the University of Notre Dame.
Postes actifs de Jeffrey W. Greve
| Sociétés | Poste | Début |
|---|---|---|
| SAGENT PHARMACEUTICALS INC | Directeur Financier/CFO | 01/09/2017 |
Formation de Jeffrey W. Greve
| University of Notre Dame | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
